Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Claudia Nardi, Bologna, Italy, Nov. 21 (CDRH).


This warning letter regarding an inspection of a manufacturing plant for endosseous implant abutments and dental attachments, June 19-22, in Bologna, Italy, did not name the firm.

The warning letter, indicating that FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 had found that the firm made changes to several of its devices since the clearance of the 510(k) for the devices, and would therefore need a new PMA PMA (papillary-marginal-attached),
n a system of epidemiologic scoring of periodontal disease devised by Schour and Massler in which the symbols denote the areas involved in gingival inflammation.

PMA Progressive muscular atrophy
, was sent to the quality manager, Claudia Nardi.

The agency requested that Nardi explain specific device changes, including modifications regarding titanium screws, dental implant dental implant
n.
An artificial tooth that is anchored in the gums or jawbone to replace a missing tooth.


dental implant 
 attachments and changes in manufacturing materials used to compose dental protective disks. Until the agency receives clarification on these issues, FDA said, the products would bee considered misbranded mis·brand  
tr.v. mis·brand·ed, mis·brand·ing, mis·brands
To brand or label misleadingly or fraudulently.

Adj. 1.
.

The dental products were also considered misbranded, according to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 the warning letter, because they failed to bear adequate directions for use for the purposes for which they were intended, and some of the labeling legends and packaging information sheets were not in English.

FDA acknowledged a written response from Nardi Oct. 23, but deemed it inadequate in that the attachments and other supporting documents were not in English and could not be thoroughly reviewed by the agency. 510(k), Design, Lab, PMA; Doc. 14050W
COPYRIGHT 2006 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:MEDICAL DEVICES
Publication:Warning Letter Bulletin
Date:Dec 1, 2006
Words:198
Previous Article:M&S Acquisition Co., LLC dba Miltronics & Skye, Cincinnati, Nov. 1 (Cincinnati).
Next Article:Perkins Electronics Co., Dallas, Nov. 2 (Dallas).
Topics:



Related Articles
CDRH UNTITLED LETTERS.
MEDICAL DEVICES.
HUMAN DRUGS.
CDRH promo untitled letters.
CDRH BiMo untitled letters.
CDRH, CBER halve output of warning letters in FY 03's first six months vs. 2002: Guaifenesin letters spike CDER totals.
Medical devices.
Medical devices.
CDRH promo untitled letters.
Unnamed Italian device firm warned for misbranding.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles